GL:NYE-Globe Life Inc (USD)

COMMON STOCK | Insurance—Life | NYE

Last Closing Price

USD 96.02

Change

-0.63 (-0.65)%

Market Cap

USD 10.12B

Volume

0.19M

Average Target Price

USD 85.27 (-11.19%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; and medicare supplement and supplemental health insurance, such as critical illness and accident plans. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-11-27 )

Largest Industry Peers for Insurance—Life

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LFC China Life Insurance Company L..

+0.63 (+5.55%)

USD150.16B 8.30 N/A
MET-PE MetLife, Inc

N/A

USD49.20B 4.12 N/A
MET-PA MetLife, Inc

-0.15 (-0.59%)

USD49.05B 3.65 N/A
MET MetLife, Inc

-0.31 (-0.65%)

USD42.98B 7.47 N/A
PUK Prudential plc

-0.30 (-0.92%)

USD42.55B 33.87 N/A
MFC Manulife Financial Corporation

+0.18 (+1.05%)

USD33.17B 8.12 N/A
AFL Aflac Incorporated

-0.33 (-0.72%)

USD32.04B 7.17 N/A
PRU Prudential Financial, Inc

-0.64 (-0.81%)

USD31.18B 8.85 N/A
LNC Lincoln National Corporation

-1.03 (-2.05%)

USD9.70B 12.82 N/A
PRI Primerica, Inc

-0.23 (-0.17%)

USD5.30B 14.51 N/A

ETFs Containing GL

Symbol Name Weight Mer Price(Change) Market Cap
FLI:CA CI First Asset U.S. &.. 0.00 % 0.75 %

-0.02 (-0.22%)

USD0.06B

Market Performance

  Market Performance vs.
Industry/Classification (Insurance—Life)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.77% 59% F 33% F
Dividend Return 0.70% 13% F 16% F
Total Return -8.07% 47% F 31% F
Trailing 12 Months  
Capital Gain -6.56% 53% F 34% F
Dividend Return 0.72% 7% F 14% F
Total Return -5.84% 47% F 31% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.76% N/A N/A 37% F
Dividend Return 0.08% N/A N/A 2% F
Total Return -0.68% N/A N/A 27% F
Risk Return Profile  
Volatility (Standard Deviation) 2.39% N/A N/A 93% A
Risk Adjusted Return -28.35% N/A N/A 19% F
Market Capitalization 10.12B 59% F 83% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Insurance—Life)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 14.16 35% F 63% D
Price/Book Ratio 1.19 25% F 60% D-
Price / Cash Flow Ratio 7.42 18% F 48% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 9.20% 59% F 65% D
Return on Invested Capital 9.50% 71% C- 70% C-
Return on Assets 2.24% 94% A 53% F
Debt to Equity Ratio 18.49% 67% D+ 82% B-
Technical Ratios  
Short Ratio 2.56 53% F 42% F
Short Percent 1.32% 92% A- 78% C+
Beta 1.11 76% C 45% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector